読み込み中
Quantum-Si incorporated operates within the life sciences sector, focusing on the creation of an advanced platform for individual molecule detection. This innovative technology is designed to streamline sample preparation and subsequent sequencing processes. The company offers a unique, proprietary single molecule detection system that draws on advancements from the semiconductor industry. This system is specifically applied to the field of proteomics, paving the way for next-generation protein sequencing. Established in 2013, Quantum-Si's headquarters are located in Guilford, Connecticut.
前日終値
$1.53
+$0.31 · +25.41%
日中の時刻はETです。市場データは遅延する場合があります。
Quantum-Si incorporated operates within the life sciences sector, focusing on the creation of an advanced platform for individual molecule detection. This innovative technology is designed to streamline sample preparation and subsequent sequencing processes. The company offers a unique, proprietary single molecule detection system that draws on advancements from the semiconductor industry. This system is specifically applied to the field of proteomics, paving the way for next-generation protein sequencing. Established in 2013, Quantum-Si's headquarters are located in Guilford, Connecticut.
日中レンジ
現在 $1.53
52週レンジ
現在 $1.53
日中の時刻はETです。市場データは遅延する場合があります。
GoAI スコア
強い売り
バリュエーション
18
著しい割高
センチメント
33
弱気
リスク
88
極めて高いリスク
モメンタム
21
弱含み
GoAIの詳細リサーチ
詳しい根拠、カタリスト、リスクを確認できます。
Quantum-Si incorporated operates within the life sciences sector, focusing on the creation of an advanced platform for individual molecule detection. This innovative technology is designed to streamline sample preparation and subsequent sequencing processes. The company offers a unique, proprietary single molecule detection system that draws on advancements from the semiconductor industry. This system is specifically applied to the field of proteomics, paving the way for next-generation protein sequencing. Established in 2013, Quantum-Si's headquarters are located in Guilford, Connecticut.
日中レンジ
現在 $1.53
52週レンジ
現在 $1.53
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標（USD） | 2025年度 | 2024年度 | 2023年度 | 2022年度 | 2021年度 |
|---|---|---|---|---|---|
| 売上高 | 243.6万 USD | 305.8万 USD | 108.2万 USD | — | — |
| 売上原価 | 128.3万 USD | 145.8万 USD | 59.4万 USD | — | — |
| 粗利益 | 115.3万 USD | 160万 USD | 48.8万 USD | — | — |
| 研究開発 | 5375.9万 USD | 5964.1万 USD | 6702.5万 USD | 7206.2万 USD | 4657.5万 USD |
| 販売・一般管理 | 4475.4万 USD | 5053.5万 USD | 4463.4万 USD | 4229.6万 USD | 5033.3万 USD |
| 営業費用 | 9851.3万 USD | 1.1億 USD | 1.12億 USD | 1.24億 USD | 9690.8万 USD |
| 受取利息 | 896.4万 USD | — | — | — | — |
| 支払利息 | — | — | — | — | 5000 USD |
| 減価償却費と償却費 | 445.4万 USD | 460万 USD | 415.6万 USD | 258.4万 USD | 104.1万 USD |
| 営業利益 | −9736万 USD | −1.09億 USD | −1.11億 USD | −1.24億 USD | −9690.8万 USD |
| 純利益 | −1.01億 USD | −1.01億 USD | −9596万 USD | −1.32億 USD | −9498.9万 USD |
会社概要が更新されました 2026年10月11日.
発表済み実績と利用可能なコンセンサス予想。
発表済み実績と利用可能なコンセンサス予想。
この株式へのエクスポージャーを報告している上場投資信託です。
ARK Genomic Revolution ETFARKG848.32万0.41%15.57億 USD0.75%$51.30+4.08%
Vanguard Morningstar Total Stock Market ETFVTI410.06万0.00%2.3兆 USD0.03%$381.94+0.63%
iShares Biotechnology ETFIBB160.36万0.02%108.2億 USD0.44%$206.49+3.00%
Vanguard Extended Market ETFVXF158.74万0.00%954億 USD0.05%$235+0.80%
Invesco RAFI US 1500 Small-Mid ETFPRFZ70.64万0.03%26.7億 USD0.36%$53.16+0.64%
iShares Core S&P Total U.S. Stock Market ETFITOT53.11万0.00%980.88億 USD0.03%$169.66+0.64%
Vanguard Health Care ETFVHT38.54万0.00%220億 USD0.09%$319.01+1.64%
EA Series Trust - EA Bridgeway Ultra-Small Company Market ETFBUSM30万0.26%1.17億 USD0.73%$15.9402+0.25%ARK Genomic Revolution ETFARKGVanguard Morningstar Total Stock Market ETFVTIiShares Biotechnology ETFIBBVanguard Extended Market ETFVXFInvesco RAFI US 1500 Small-Mid ETFPRFZiShares Core S&P Total U.S. Stock Market ETFITOTVanguard Health Care ETFVHTEA Series Trust - EA Bridgeway Ultra-Small Company Market ETFBUSMAIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。
